Moreover, the promoter methylation of several other genes (i.e., p16INK4A, RASSF1A, NORE1A, p16INK4A, RARB, DCR2, CDH1, and APC) has been shown to influence tumor aggressiveness [36,37,38]. This evidence concerns the gene CDKN2A and neoplasm.